nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B1—Verapamil—migraine	0.226	0.371	CbGbCtD
Valsartan—ALB—Amitriptyline—migraine	0.156	0.256	CbGbCtD
Valsartan—CYP2C9—Amitriptyline—migraine	0.0842	0.138	CbGbCtD
Valsartan—CYP2C9—Valproic Acid—migraine	0.0767	0.126	CbGbCtD
Valsartan—CYP2C9—Verapamil—migraine	0.0668	0.109	CbGbCtD
Valsartan—Irbesartan—EDNRA—migraine	0.00774	0.801	CrCbGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—ACE—migraine	0.00225	0.0822	CbGpPWpGaD
Valsartan—Losartan—ACE—migraine	0.00192	0.199	CrCbGaD
Valsartan—ALB—Scavenging of heme from plasma—LRP1—migraine	0.00148	0.054	CbGpPWpGaD
Valsartan—Back pain—Valproic Acid—migraine	0.000767	0.00217	CcSEcCtD
Valsartan—Headache—Amitriptyline—migraine	0.000764	0.00216	CcSEcCtD
Valsartan—Bronchitis—Topiramate—migraine	0.000763	0.00216	CcSEcCtD
Valsartan—Muscle spasms—Valproic Acid—migraine	0.000762	0.00216	CcSEcCtD
Valsartan—Rhinitis—Gabapentin—migraine	0.000757	0.00215	CcSEcCtD
Valsartan—Haemorrhage—Gabapentin—migraine	0.000755	0.00214	CcSEcCtD
Valsartan—Hepatitis—Gabapentin—migraine	0.000755	0.00214	CcSEcCtD
Valsartan—Cardiac disorder—Timolol—migraine	0.000753	0.00213	CcSEcCtD
Valsartan—Pharyngitis—Gabapentin—migraine	0.00075	0.00212	CcSEcCtD
Valsartan—Vision blurred—Valproic Acid—migraine	0.000747	0.00212	CcSEcCtD
Valsartan—Urinary tract disorder—Gabapentin—migraine	0.000746	0.00211	CcSEcCtD
Valsartan—Neutropenia—Topiramate—migraine	0.000742	0.0021	CcSEcCtD
Valsartan—Connective tissue disorder—Gabapentin—migraine	0.000742	0.0021	CcSEcCtD
Valsartan—Urethral disorder—Gabapentin—migraine	0.00074	0.0021	CcSEcCtD
Valsartan—Upper respiratory tract infection—Topiramate—migraine	0.000738	0.00209	CcSEcCtD
Valsartan—AGTR1—Peptide GPCRs—EDNRA—migraine	0.000737	0.0269	CbGpPWpGaD
Valsartan—Angiopathy—Timolol—migraine	0.000736	0.00209	CcSEcCtD
Valsartan—Immune system disorder—Timolol—migraine	0.000733	0.00208	CcSEcCtD
Valsartan—Hypersensitivity—Propranolol—migraine	0.000731	0.00207	CcSEcCtD
Valsartan—Erectile dysfunction—Topiramate—migraine	0.000731	0.00207	CcSEcCtD
Valsartan—Mediastinal disorder—Timolol—migraine	0.000731	0.00207	CcSEcCtD
Valsartan—Urticaria—Verapamil—migraine	0.000725	0.00206	CcSEcCtD
Valsartan—Angioedema—Valproic Acid—migraine	0.000725	0.00205	CcSEcCtD
Valsartan—Photosensitivity reaction—Topiramate—migraine	0.000725	0.00205	CcSEcCtD
Valsartan—Nausea—Amitriptyline—migraine	0.000724	0.00205	CcSEcCtD
Valsartan—Alopecia—Timolol—migraine	0.000717	0.00203	CcSEcCtD
Valsartan—Vertigo—Valproic Acid—migraine	0.000713	0.00202	CcSEcCtD
Valsartan—Asthenia—Propranolol—migraine	0.000712	0.00202	CcSEcCtD
Valsartan—Mental disorder—Timolol—migraine	0.000711	0.00201	CcSEcCtD
Valsartan—Infestation NOS—Topiramate—migraine	0.000708	0.00201	CcSEcCtD
Valsartan—Infestation—Topiramate—migraine	0.000708	0.00201	CcSEcCtD
Valsartan—Malnutrition—Timolol—migraine	0.000706	0.002	CcSEcCtD
Valsartan—Cardiac disorder—Gabapentin—migraine	0.000701	0.00199	CcSEcCtD
Valsartan—Palpitations—Valproic Acid—migraine	0.000701	0.00199	CcSEcCtD
Valsartan—Renal failure—Topiramate—migraine	0.000696	0.00197	CcSEcCtD
Valsartan—Cough—Valproic Acid—migraine	0.000692	0.00196	CcSEcCtD
Valsartan—Dysgeusia—Timolol—migraine	0.000691	0.00196	CcSEcCtD
Valsartan—Immune system disorder—Gabapentin—migraine	0.000682	0.00193	CcSEcCtD
Valsartan—Mediastinal disorder—Gabapentin—migraine	0.000681	0.00193	CcSEcCtD
Valsartan—Diarrhoea—Propranolol—migraine	0.000679	0.00192	CcSEcCtD
Valsartan—Chest pain—Valproic Acid—migraine	0.000675	0.00191	CcSEcCtD
Valsartan—Myalgia—Valproic Acid—migraine	0.000675	0.00191	CcSEcCtD
Valsartan—Arthralgia—Valproic Acid—migraine	0.000675	0.00191	CcSEcCtD
Valsartan—Anxiety—Valproic Acid—migraine	0.000673	0.00191	CcSEcCtD
Valsartan—Hypersensitivity—Verapamil—migraine	0.000673	0.00191	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000671	0.0019	CcSEcCtD
Valsartan—Epistaxis—Topiramate—migraine	0.000668	0.00189	CcSEcCtD
Valsartan—Alopecia—Gabapentin—migraine	0.000667	0.00189	CcSEcCtD
Valsartan—Vision blurred—Timolol—migraine	0.000665	0.00189	CcSEcCtD
Valsartan—Sinusitis—Topiramate—migraine	0.000664	0.00188	CcSEcCtD
Valsartan—Mental disorder—Gabapentin—migraine	0.000662	0.00188	CcSEcCtD
Valsartan—Dry mouth—Valproic Acid—migraine	0.00066	0.00187	CcSEcCtD
Valsartan—Malnutrition—Gabapentin—migraine	0.000657	0.00186	CcSEcCtD
Valsartan—Dizziness—Propranolol—migraine	0.000656	0.00186	CcSEcCtD
Valsartan—Asthenia—Verapamil—migraine	0.000655	0.00186	CcSEcCtD
Valsartan—Flatulence—Gabapentin—migraine	0.000648	0.00184	CcSEcCtD
Valsartan—Oedema—Valproic Acid—migraine	0.000647	0.00183	CcSEcCtD
Valsartan—Anaphylactic shock—Valproic Acid—migraine	0.000647	0.00183	CcSEcCtD
Valsartan—Pruritus—Verapamil—migraine	0.000646	0.00183	CcSEcCtD
Valsartan—Angioedema—Timolol—migraine	0.000645	0.00183	CcSEcCtD
Valsartan—Dysgeusia—Gabapentin—migraine	0.000644	0.00182	CcSEcCtD
Valsartan—Infection—Valproic Acid—migraine	0.000643	0.00182	CcSEcCtD
Valsartan—Haemoglobin—Topiramate—migraine	0.000639	0.00181	CcSEcCtD
Valsartan—Rhinitis—Topiramate—migraine	0.000637	0.00181	CcSEcCtD
Valsartan—Back pain—Gabapentin—migraine	0.000636	0.0018	CcSEcCtD
Valsartan—Haemorrhage—Topiramate—migraine	0.000635	0.0018	CcSEcCtD
Valsartan—Hepatitis—Topiramate—migraine	0.000635	0.0018	CcSEcCtD
Valsartan—Nervous system disorder—Valproic Acid—migraine	0.000635	0.0018	CcSEcCtD
Valsartan—Vertigo—Timolol—migraine	0.000634	0.0018	CcSEcCtD
Valsartan—Thrombocytopenia—Valproic Acid—migraine	0.000634	0.0018	CcSEcCtD
Valsartan—Syncope—Timolol—migraine	0.000633	0.00179	CcSEcCtD
Valsartan—Muscle spasms—Gabapentin—migraine	0.000632	0.00179	CcSEcCtD
Valsartan—Vomiting—Propranolol—migraine	0.000631	0.00179	CcSEcCtD
Valsartan—Pharyngitis—Topiramate—migraine	0.000631	0.00179	CcSEcCtD
Valsartan—Skin disorder—Valproic Acid—migraine	0.000629	0.00178	CcSEcCtD
Valsartan—Urinary tract disorder—Topiramate—migraine	0.000627	0.00178	CcSEcCtD
Valsartan—Rash—Propranolol—migraine	0.000626	0.00177	CcSEcCtD
Valsartan—Dermatitis—Propranolol—migraine	0.000625	0.00177	CcSEcCtD
Valsartan—Diarrhoea—Verapamil—migraine	0.000625	0.00177	CcSEcCtD
Valsartan—Connective tissue disorder—Topiramate—migraine	0.000624	0.00177	CcSEcCtD
Valsartan—Palpitations—Timolol—migraine	0.000624	0.00177	CcSEcCtD
Valsartan—Urethral disorder—Topiramate—migraine	0.000623	0.00177	CcSEcCtD
Valsartan—Loss of consciousness—Timolol—migraine	0.000621	0.00176	CcSEcCtD
Valsartan—Vision blurred—Gabapentin—migraine	0.00062	0.00176	CcSEcCtD
Valsartan—Anorexia—Valproic Acid—migraine	0.000617	0.00175	CcSEcCtD
Valsartan—Cough—Timolol—migraine	0.000616	0.00175	CcSEcCtD
Valsartan—Hypotension—Valproic Acid—migraine	0.000605	0.00171	CcSEcCtD
Valsartan—Dizziness—Verapamil—migraine	0.000604	0.00171	CcSEcCtD
Valsartan—Arthralgia—Timolol—migraine	0.000601	0.0017	CcSEcCtD
Valsartan—Myalgia—Timolol—migraine	0.000601	0.0017	CcSEcCtD
Valsartan—Chest pain—Timolol—migraine	0.000601	0.0017	CcSEcCtD
Valsartan—Angioedema—Gabapentin—migraine	0.000601	0.0017	CcSEcCtD
Valsartan—Anxiety—Timolol—migraine	0.000599	0.0017	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000597	0.00169	CcSEcCtD
Valsartan—AGTR1—G alpha (q) signalling events—HTR2B—migraine	0.000595	0.0217	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000591	0.0215	CbGpPWpGaD
Valsartan—Vertigo—Gabapentin—migraine	0.000591	0.00167	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Valproic Acid—migraine	0.00059	0.00167	CcSEcCtD
Valsartan—Cardiac disorder—Topiramate—migraine	0.00059	0.00167	CcSEcCtD
Valsartan—Syncope—Gabapentin—migraine	0.00059	0.00167	CcSEcCtD
Valsartan—Nausea—Propranolol—migraine	0.000589	0.00167	CcSEcCtD
Valsartan—Dry mouth—Timolol—migraine	0.000588	0.00167	CcSEcCtD
Valsartan—Insomnia—Valproic Acid—migraine	0.000585	0.00166	CcSEcCtD
Valsartan—Paraesthesia—Valproic Acid—migraine	0.000581	0.00165	CcSEcCtD
Valsartan—Palpitations—Gabapentin—migraine	0.000581	0.00165	CcSEcCtD
Valsartan—Vomiting—Verapamil—migraine	0.00058	0.00165	CcSEcCtD
Valsartan—Loss of consciousness—Gabapentin—migraine	0.000578	0.00164	CcSEcCtD
Valsartan—Dyspnoea—Valproic Acid—migraine	0.000577	0.00164	CcSEcCtD
Valsartan—Angiopathy—Topiramate—migraine	0.000576	0.00163	CcSEcCtD
Valsartan—Oedema—Timolol—migraine	0.000576	0.00163	CcSEcCtD
Valsartan—Anaphylactic shock—Timolol—migraine	0.000576	0.00163	CcSEcCtD
Valsartan—Rash—Verapamil—migraine	0.000576	0.00163	CcSEcCtD
Valsartan—Somnolence—Valproic Acid—migraine	0.000575	0.00163	CcSEcCtD
Valsartan—Dermatitis—Verapamil—migraine	0.000575	0.00163	CcSEcCtD
Valsartan—Immune system disorder—Topiramate—migraine	0.000574	0.00163	CcSEcCtD
Valsartan—Cough—Gabapentin—migraine	0.000574	0.00163	CcSEcCtD
Valsartan—Mediastinal disorder—Topiramate—migraine	0.000573	0.00162	CcSEcCtD
Valsartan—Infection—Timolol—migraine	0.000572	0.00162	CcSEcCtD
Valsartan—Headache—Verapamil—migraine	0.000572	0.00162	CcSEcCtD
Valsartan—Dyspepsia—Valproic Acid—migraine	0.00057	0.00161	CcSEcCtD
Valsartan—Shock—Timolol—migraine	0.000567	0.00161	CcSEcCtD
Valsartan—Nervous system disorder—Timolol—migraine	0.000565	0.0016	CcSEcCtD
Valsartan—Decreased appetite—Valproic Acid—migraine	0.000563	0.00159	CcSEcCtD
Valsartan—Alopecia—Topiramate—migraine	0.000561	0.00159	CcSEcCtD
Valsartan—Myalgia—Gabapentin—migraine	0.00056	0.00159	CcSEcCtD
Valsartan—Arthralgia—Gabapentin—migraine	0.00056	0.00159	CcSEcCtD
Valsartan—Chest pain—Gabapentin—migraine	0.00056	0.00159	CcSEcCtD
Valsartan—Skin disorder—Timolol—migraine	0.00056	0.00159	CcSEcCtD
Valsartan—Gastrointestinal disorder—Valproic Acid—migraine	0.000559	0.00158	CcSEcCtD
Valsartan—Fatigue—Valproic Acid—migraine	0.000558	0.00158	CcSEcCtD
Valsartan—Anxiety—Gabapentin—migraine	0.000558	0.00158	CcSEcCtD
Valsartan—Mental disorder—Topiramate—migraine	0.000557	0.00158	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000556	0.00158	CcSEcCtD
Valsartan—Constipation—Valproic Acid—migraine	0.000553	0.00157	CcSEcCtD
Valsartan—Malnutrition—Topiramate—migraine	0.000553	0.00157	CcSEcCtD
Valsartan—Anorexia—Timolol—migraine	0.000549	0.00156	CcSEcCtD
Valsartan—Dry mouth—Gabapentin—migraine	0.000547	0.00155	CcSEcCtD
Valsartan—Flatulence—Topiramate—migraine	0.000545	0.00154	CcSEcCtD
Valsartan—Nausea—Verapamil—migraine	0.000542	0.00154	CcSEcCtD
Valsartan—Dysgeusia—Topiramate—migraine	0.000542	0.00154	CcSEcCtD
Valsartan—Hypotension—Timolol—migraine	0.000538	0.00153	CcSEcCtD
Valsartan—Oedema—Gabapentin—migraine	0.000537	0.00152	CcSEcCtD
Valsartan—Anaphylactic shock—Gabapentin—migraine	0.000537	0.00152	CcSEcCtD
Valsartan—Back pain—Topiramate—migraine	0.000535	0.00152	CcSEcCtD
Valsartan—Infection—Gabapentin—migraine	0.000533	0.00151	CcSEcCtD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000532	0.0194	CbGpPWpGaD
Valsartan—Muscle spasms—Topiramate—migraine	0.000532	0.00151	CcSEcCtD
Valsartan—Gastrointestinal pain—Valproic Acid—migraine	0.000529	0.0015	CcSEcCtD
Valsartan—Shock—Gabapentin—migraine	0.000528	0.0015	CcSEcCtD
Valsartan—Nervous system disorder—Gabapentin—migraine	0.000526	0.00149	CcSEcCtD
Valsartan—Thrombocytopenia—Gabapentin—migraine	0.000525	0.00149	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Timolol—migraine	0.000525	0.00149	CcSEcCtD
Valsartan—Vision blurred—Topiramate—migraine	0.000521	0.00148	CcSEcCtD
Valsartan—Skin disorder—Gabapentin—migraine	0.000521	0.00148	CcSEcCtD
Valsartan—Insomnia—Timolol—migraine	0.000521	0.00148	CcSEcCtD
Valsartan—Paraesthesia—Timolol—migraine	0.000517	0.00147	CcSEcCtD
Valsartan—Urticaria—Valproic Acid—migraine	0.000514	0.00146	CcSEcCtD
Valsartan—Dyspnoea—Timolol—migraine	0.000514	0.00146	CcSEcCtD
Valsartan—Somnolence—Timolol—migraine	0.000512	0.00145	CcSEcCtD
Valsartan—Abdominal pain—Valproic Acid—migraine	0.000512	0.00145	CcSEcCtD
Valsartan—Anorexia—Gabapentin—migraine	0.000511	0.00145	CcSEcCtD
Valsartan—Dyspepsia—Timolol—migraine	0.000507	0.00144	CcSEcCtD
Valsartan—Hypotension—Gabapentin—migraine	0.000501	0.00142	CcSEcCtD
Valsartan—Decreased appetite—Timolol—migraine	0.000501	0.00142	CcSEcCtD
Valsartan—Gastrointestinal disorder—Timolol—migraine	0.000497	0.00141	CcSEcCtD
Valsartan—Vertigo—Topiramate—migraine	0.000497	0.00141	CcSEcCtD
Valsartan—Fatigue—Timolol—migraine	0.000497	0.00141	CcSEcCtD
Valsartan—Syncope—Topiramate—migraine	0.000496	0.00141	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000495	0.018	CbGpPWpGaD
Valsartan—Musculoskeletal discomfort—Gabapentin—migraine	0.000489	0.00139	CcSEcCtD
Valsartan—Palpitations—Topiramate—migraine	0.000489	0.00139	CcSEcCtD
Valsartan—Loss of consciousness—Topiramate—migraine	0.000486	0.00138	CcSEcCtD
Valsartan—Insomnia—Gabapentin—migraine	0.000485	0.00138	CcSEcCtD
Valsartan—Cough—Topiramate—migraine	0.000483	0.00137	CcSEcCtD
Valsartan—Paraesthesia—Gabapentin—migraine	0.000482	0.00137	CcSEcCtD
Valsartan—Dyspnoea—Gabapentin—migraine	0.000478	0.00136	CcSEcCtD
Valsartan—Somnolence—Gabapentin—migraine	0.000477	0.00135	CcSEcCtD
Valsartan—Hypersensitivity—Valproic Acid—migraine	0.000477	0.00135	CcSEcCtD
Valsartan—Dyspepsia—Gabapentin—migraine	0.000472	0.00134	CcSEcCtD
Valsartan—Gastrointestinal pain—Timolol—migraine	0.000471	0.00134	CcSEcCtD
Valsartan—Arthralgia—Topiramate—migraine	0.000471	0.00133	CcSEcCtD
Valsartan—Myalgia—Topiramate—migraine	0.000471	0.00133	CcSEcCtD
Valsartan—Chest pain—Topiramate—migraine	0.000471	0.00133	CcSEcCtD
Valsartan—Anxiety—Topiramate—migraine	0.000469	0.00133	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000468	0.00133	CcSEcCtD
Valsartan—Decreased appetite—Gabapentin—migraine	0.000466	0.00132	CcSEcCtD
Valsartan—Asthenia—Valproic Acid—migraine	0.000464	0.00132	CcSEcCtD
Valsartan—Gastrointestinal disorder—Gabapentin—migraine	0.000463	0.00131	CcSEcCtD
Valsartan—Fatigue—Gabapentin—migraine	0.000463	0.00131	CcSEcCtD
Valsartan—Dry mouth—Topiramate—migraine	0.000461	0.00131	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00046	0.0168	CbGpPWpGaD
Valsartan—Constipation—Gabapentin—migraine	0.000459	0.0013	CcSEcCtD
Valsartan—Pruritus—Valproic Acid—migraine	0.000458	0.0013	CcSEcCtD
Valsartan—Urticaria—Timolol—migraine	0.000458	0.0013	CcSEcCtD
Valsartan—Abdominal pain—Timolol—migraine	0.000455	0.00129	CcSEcCtD
Valsartan—Oedema—Topiramate—migraine	0.000451	0.00128	CcSEcCtD
Valsartan—Infection—Topiramate—migraine	0.000448	0.00127	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—RAMP1—migraine	0.000444	0.0162	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CALCRL—migraine	0.000444	0.0162	CbGpPWpGaD
Valsartan—Shock—Topiramate—migraine	0.000444	0.00126	CcSEcCtD
Valsartan—Diarrhoea—Valproic Acid—migraine	0.000443	0.00126	CcSEcCtD
Valsartan—Nervous system disorder—Topiramate—migraine	0.000443	0.00125	CcSEcCtD
Valsartan—Thrombocytopenia—Topiramate—migraine	0.000442	0.00125	CcSEcCtD
Valsartan—Gastrointestinal pain—Gabapentin—migraine	0.000439	0.00124	CcSEcCtD
Valsartan—Skin disorder—Topiramate—migraine	0.000438	0.00124	CcSEcCtD
Valsartan—Anorexia—Topiramate—migraine	0.00043	0.00122	CcSEcCtD
Valsartan—Dizziness—Valproic Acid—migraine	0.000428	0.00121	CcSEcCtD
Valsartan—Urticaria—Gabapentin—migraine	0.000426	0.00121	CcSEcCtD
Valsartan—Hypersensitivity—Timolol—migraine	0.000425	0.0012	CcSEcCtD
Valsartan—Abdominal pain—Gabapentin—migraine	0.000424	0.0012	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000424	0.0155	CbGpPWpGaD
Valsartan—Hypotension—Topiramate—migraine	0.000422	0.0012	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—TRPM8—migraine	0.000415	0.0151	CbGpPWpGaD
Valsartan—Asthenia—Timolol—migraine	0.000413	0.00117	CcSEcCtD
Valsartan—Vomiting—Valproic Acid—migraine	0.000412	0.00117	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Topiramate—migraine	0.000411	0.00117	CcSEcCtD
Valsartan—Insomnia—Topiramate—migraine	0.000408	0.00116	CcSEcCtD
Valsartan—Rash—Valproic Acid—migraine	0.000408	0.00116	CcSEcCtD
Valsartan—Dermatitis—Valproic Acid—migraine	0.000408	0.00116	CcSEcCtD
Valsartan—Pruritus—Timolol—migraine	0.000408	0.00116	CcSEcCtD
Valsartan—Headache—Valproic Acid—migraine	0.000405	0.00115	CcSEcCtD
Valsartan—Paraesthesia—Topiramate—migraine	0.000405	0.00115	CcSEcCtD
Valsartan—Dyspnoea—Topiramate—migraine	0.000402	0.00114	CcSEcCtD
Valsartan—Somnolence—Topiramate—migraine	0.000401	0.00114	CcSEcCtD
Valsartan—Dyspepsia—Topiramate—migraine	0.000397	0.00113	CcSEcCtD
Valsartan—Hypersensitivity—Gabapentin—migraine	0.000395	0.00112	CcSEcCtD
Valsartan—Diarrhoea—Timolol—migraine	0.000394	0.00112	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000394	0.0144	CbGpPWpGaD
Valsartan—Decreased appetite—Topiramate—migraine	0.000392	0.00111	CcSEcCtD
Valsartan—Gastrointestinal disorder—Topiramate—migraine	0.00039	0.0011	CcSEcCtD
Valsartan—Fatigue—Topiramate—migraine	0.000389	0.0011	CcSEcCtD
Valsartan—Constipation—Topiramate—migraine	0.000386	0.00109	CcSEcCtD
Valsartan—Asthenia—Gabapentin—migraine	0.000385	0.00109	CcSEcCtD
Valsartan—Nausea—Valproic Acid—migraine	0.000384	0.00109	CcSEcCtD
Valsartan—Dizziness—Timolol—migraine	0.000381	0.00108	CcSEcCtD
Valsartan—Pruritus—Gabapentin—migraine	0.00038	0.00108	CcSEcCtD
Valsartan—Gastrointestinal pain—Topiramate—migraine	0.000369	0.00105	CcSEcCtD
Valsartan—AGTR1—G alpha (q) signalling events—TAC1—migraine	0.000368	0.0134	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—NPS—migraine	0.000368	0.0134	CbGpPWpGaD
Valsartan—Diarrhoea—Gabapentin—migraine	0.000367	0.00104	CcSEcCtD
Valsartan—Vomiting—Timolol—migraine	0.000366	0.00104	CcSEcCtD
Valsartan—Rash—Timolol—migraine	0.000363	0.00103	CcSEcCtD
Valsartan—AGTR1—Peptide ligand-binding receptors—NPS—migraine	0.000363	0.0132	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—TAC1—migraine	0.000363	0.0132	CbGpPWpGaD
Valsartan—Dermatitis—Timolol—migraine	0.000363	0.00103	CcSEcCtD
Valsartan—Headache—Timolol—migraine	0.000361	0.00102	CcSEcCtD
Valsartan—AGTR1—G alpha (q) signalling events—HTR2C—migraine	0.000361	0.0131	CbGpPWpGaD
Valsartan—Urticaria—Topiramate—migraine	0.000359	0.00102	CcSEcCtD
Valsartan—Abdominal pain—Topiramate—migraine	0.000357	0.00101	CcSEcCtD
Valsartan—Dizziness—Gabapentin—migraine	0.000355	0.00101	CcSEcCtD
Valsartan—AGTR1—G alpha (q) signalling events—EDNRA—migraine	0.000351	0.0128	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—EDNRA—migraine	0.000346	0.0126	CbGpPWpGaD
Valsartan—Nausea—Timolol—migraine	0.000342	0.00097	CcSEcCtD
Valsartan—Vomiting—Gabapentin—migraine	0.000341	0.000967	CcSEcCtD
Valsartan—Rash—Gabapentin—migraine	0.000338	0.000959	CcSEcCtD
Valsartan—Dermatitis—Gabapentin—migraine	0.000338	0.000958	CcSEcCtD
Valsartan—Headache—Gabapentin—migraine	0.000336	0.000953	CcSEcCtD
Valsartan—Hypersensitivity—Topiramate—migraine	0.000333	0.000943	CcSEcCtD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000329	0.012	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000329	0.012	CbGpPWpGaD
Valsartan—Asthenia—Topiramate—migraine	0.000324	0.000918	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—HTR1D—migraine	0.000323	0.0118	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000323	0.0118	CbGpPWpGaD
Valsartan—Pruritus—Topiramate—migraine	0.000319	0.000905	CcSEcCtD
Valsartan—Nausea—Gabapentin—migraine	0.000319	0.000903	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000315	0.0115	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000315	0.0115	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000314	0.0114	CbGpPWpGaD
Valsartan—Diarrhoea—Topiramate—migraine	0.000309	0.000875	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—HTR2B—migraine	0.0003	0.0109	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.0003	0.0109	CbGpPWpGaD
Valsartan—Dizziness—Topiramate—migraine	0.000299	0.000846	CcSEcCtD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000289	0.0105	CbGpPWpGaD
Valsartan—Vomiting—Topiramate—migraine	0.000287	0.000814	CcSEcCtD
Valsartan—Rash—Topiramate—migraine	0.000285	0.000807	CcSEcCtD
Valsartan—Dermatitis—Topiramate—migraine	0.000284	0.000806	CcSEcCtD
Valsartan—Headache—Topiramate—migraine	0.000283	0.000802	CcSEcCtD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	0.000279	0.0102	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000279	0.0102	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000273	0.00996	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000271	0.00989	CbGpPWpGaD
Valsartan—Nausea—Topiramate—migraine	0.000268	0.00076	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—HTR3A—migraine	0.000268	0.00975	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000257	0.00937	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CALCRL—migraine	0.000251	0.00916	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—RAMP1—migraine	0.000251	0.00916	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000247	0.00902	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000244	0.0089	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000244	0.00888	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000244	0.00888	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000239	0.00871	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000232	0.00847	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—RAMP1—migraine	0.000228	0.00832	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CALCRL—migraine	0.000228	0.00832	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—HTR2A—migraine	0.000221	0.00807	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000211	0.00771	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000211	0.00771	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000209	0.00763	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000209	0.00763	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000198	0.00721	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR1B—migraine	0.000196	0.00713	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—TNF—migraine	0.00019	0.00691	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR1A—migraine	0.000188	0.00687	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—NPS—migraine	0.000185	0.00676	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—TAC1—migraine	0.000185	0.00676	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR1D—migraine	0.000182	0.00665	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR2C—migraine	0.000182	0.00663	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	0.00018	0.00655	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—EDNRA—migraine	0.000177	0.00645	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000171	0.00623	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CALCA—migraine	0.00017	0.00621	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—MTHFR—migraine	0.00017	0.00621	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2B—migraine	0.00017	0.00619	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR1D—migraine	0.000166	0.00604	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—TRPM8—migraine	0.000159	0.00581	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR7—migraine	0.000159	0.00581	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2B—migraine	0.000154	0.00562	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000147	0.00534	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—MTHFR—migraine	0.000135	0.00493	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RAMP1—migraine	0.000135	0.00491	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CALCRL—migraine	0.000135	0.00491	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	0.000121	0.0044	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	0.000121	0.0044	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—HTR2A—migraine	0.000112	0.00407	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR1B—migraine	0.000111	0.00403	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CACNA1A—migraine	0.000107	0.00388	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR1A—migraine	0.000106	0.00388	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—TAC1—migraine	0.000105	0.00382	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—NPS—migraine	0.000105	0.00382	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2C—migraine	0.000103	0.00375	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—HTR3A—migraine	0.000103	0.00374	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR1B—migraine	0.0001	0.00366	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—EDNRA—migraine	0.0001	0.00365	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1D—migraine	9.79e-05	0.00357	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR1A—migraine	9.66e-05	0.00352	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CALCA—migraine	9.62e-05	0.00351	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TAC1—migraine	9.52e-05	0.00347	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—NPS—migraine	9.52e-05	0.00347	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2C—migraine	9.33e-05	0.0034	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2B—migraine	9.1e-05	0.00332	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EDNRA—migraine	9.08e-05	0.00331	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—migraine	9.01e-05	0.00329	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR7—migraine	9e-05	0.00328	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CALCA—migraine	8.74e-05	0.00319	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR7—migraine	8.18e-05	0.00298	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LRP1—migraine	8.01e-05	0.00292	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—migraine	7.33e-05	0.00267	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CACNA1A—migraine	7.16e-05	0.00261	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—migraine	6.31e-05	0.0023	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOTCH4—migraine	6.15e-05	0.00224	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1B—migraine	5.93e-05	0.00216	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—migraine	5.82e-05	0.00212	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—migraine	5.73e-05	0.00209	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1A—migraine	5.71e-05	0.00208	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PGR—migraine	5.62e-05	0.00205	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TAC1—migraine	5.62e-05	0.00205	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPS—migraine	5.62e-05	0.00205	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2C—migraine	5.51e-05	0.00201	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EDNRA—migraine	5.36e-05	0.00196	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOTCH3—migraine	5.23e-05	0.00191	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CALCA—migraine	5.16e-05	0.00188	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR7—migraine	4.83e-05	0.00176	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFBR2—migraine	4.16e-05	0.00152	CbGpPWpGaD
Valsartan—ALB—Metabolism—CACNA1A—migraine	4.09e-05	0.00149	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—migraine	3.52e-05	0.00129	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—migraine	3.38e-05	0.00123	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CACNA1A—migraine	3.35e-05	0.00122	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ESR1—migraine	3e-05	0.00109	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—migraine	2.37e-05	0.000863	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—migraine	1.35e-05	0.000493	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—migraine	1.11e-05	0.000404	CbGpPWpGaD
